- Reference code :
- wf391
- Published date :
-
02 May 2001
- Expired date :
-
17 September 2028
AstraZeneca announced today that the United States District Court for the Southern District of New York has denied a summary judgement motion filed by Reddy-Cheminor alleging invalidity of a patent (US patent no:4,255,431) at issue in a lawsuit. The patent relates to omeprazole, the active ingredient in Prilosec®, a treatment for stomach acid disorders.
Further enquires to:
Media RelationsSteve Brown +44 (0)20 7304 5033 Lucy Williams +44 (0)20 7304 5034 |
Investor RelationsMichael Olsson +44 (0)20 7304 5087 |
Note to News Editors: |
|
|
|
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 06:04 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
